Chiroscience use Ductch Elm disease enzyme

6 August 1995

- Chiroscience of the UK has cloned an enzyme present in the Dutch Elm disease fungus, Ophiostomi novoulmi, which can be used in the hydrolysis of an ester precursor of ketoprofen to its single-isomer form, dexketoprofen. The company is applying the discovery to the large-scale production of dexketoprofen for its partner Menarini. Dexketoprofen, a non-steroidal anti-inflammatory with advantages over the racemate version, is in the late stages of regulatory review in Spain and a launch is expected there in 1995, according to Chiroscience.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight